Two Sigma Advisers’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-49,400
| Closed | -$89K | – | 2805 |
|
|
2022
Q2 | $89K | Sell |
49,400
-69,100
| -58% | -$124K | ﹤0.01% | 2400 |
|
|
2022
Q1 | $239K | Sell |
118,500
-106,400
| -47% | -$215K | ﹤0.01% | 2326 |
|
|
2021
Q4 | $609K | Buy |
224,900
+159,000
| +241% | +$431K | ﹤0.01% | 1818 |
|
|
2021
Q3 | $294K | Buy |
+65,900
| New | +$294K | ﹤0.01% | 2129 |
|
|
2020
Q2 | – | Sell |
-25,100
| Closed | -$160K | – | 2637 |
|
|
2020
Q1 | $160K | Buy |
+25,100
| New | +$160K | ﹤0.01% | 2222 |
|
|
2019
Q4 | – | Sell |
-743,706
| Closed | -$2.92M | – | 2510 |
|
|
2019
Q3 | $2.92M | Buy |
743,706
+686,400
| +1,198% | +$2.7M | 0.01% | 971 |
|
|
2019
Q2 | $852K | Buy |
57,306
+35,106
| +158% | +$522K | ﹤0.01% | 1600 |
|
|
2019
Q1 | $551K | Buy |
+22,200
| New | +$551K | ﹤0.01% | 1755 |
|
|
2018
Q1 | – | Sell |
-48,400
| Closed | -$3.29M | – | 2455 |
|
|
2017
Q4 | $3.29M | Buy |
+48,400
| New | +$3.29M | 0.01% | 1020 |
|
|
2017
Q3 | – | Sell |
-4,700
| Closed | -$440K | – | 2386 |
|
|
2017
Q2 | $440K | Sell |
4,700
-9,200
| -66% | -$861K | ﹤0.01% | 1836 |
|
|
2017
Q1 | $885K | Buy |
+13,900
| New | +$885K | ﹤0.01% | 1646 |
|
|
2016
Q1 | – | Sell |
-27,601
| Closed | -$966K | – | 2171 |
|
|
2015
Q4 | $966K | Buy |
27,601
+17,195
| +165% | +$602K | 0.01% | 1036 |
|
|
2015
Q3 | $957K | Buy |
+10,406
| New | +$957K | 0.01% | 1024 |
|
|
2014
Q3 | – | Sell |
-12,806
| Closed | -$530K | – | 2080 |
|
|
2014
Q2 | $530K | Buy |
+12,806
| New | +$530K | ﹤0.01% | 1320 |
|